Unicycive Therapeutics (UNCY) Earnings Date & Reports

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

UNCY is expected to report earnings to fall 34.81% to -35 cents per share on November 18

Unicycive Therapeutics UNCY Stock Earnings Reports

Q3'26

Est.

$-0.35

Q1'26

Missed

by $0.66

Q4'25

Missed

by $0.65

Q3'25

Missed

by $0.26

Q2'25

Missed

by $1.43

The last earnings report on May 12 showed earnings per share of -54 cents, missing the estimate of 11 cents. With 411.46K shares outstanding, the current market capitalization sits at 140.67M.

View a ticker or compare two or three

UNCY

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days